Dyne Therapeutics, Inc. S-8, filed Mar 10, 2022: EX-23.1
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 10, 2022, relating to the financial statements of Dyne Therapeutics, Inc. appearing in the Annual Report on Form 10-K of Dyne Therapeutics, Inc. for the year ended December 31, 2021.
|
/s/ Deloitte & Touche LLP |
|
|
|
|
|
Boston, Massachusetts |
|
|
March 10, 2022 |
|